The myelodepletive phenotype is associated with progressive anemia and/or thrombocytopenia, modest splenomegaly, more high molecular risk mutations, lower mutant JAK2 allele burden, and inferior outcomes. This evidence concerns the gene JAK2 and Splenomegaly.